Piper Sandler Reaffirms “Neutral” Rating for Tempus AI (NASDAQ:TEM)

Piper Sandler restated their neutral rating on shares of Tempus AI (NASDAQ:TEM) in a report released on Tuesday morning,Benzinga reports. The firm currently has a $70.00 target price on the stock, up from their prior target price of $40.00.

Several other research firms have also weighed in on TEM. Loop Capital raised their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $45.00 to $65.00 in a research note on Monday. JPMorgan Chase & Co. raised their target price on Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Needham & Company LLC reissued a “buy” rating and set a $47.00 price objective on shares of Tempus AI in a report on Wednesday, August 7th. Finally, Bank of America downgraded shares of Tempus AI from a “buy” rating to a “neutral” rating and boosted their target price for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $54.22.

Tempus AI Stock Down 16.8 %

TEM opened at $56.63 on Tuesday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The stock has a 50-day moving average price of $51.21. Tempus AI has a twelve month low of $22.89 and a twelve month high of $79.49.

Institutional Trading of Tempus AI

Institutional investors and hedge funds have recently made changes to their positions in the business. Dakota Wealth Management acquired a new stake in shares of Tempus AI during the third quarter worth $1,185,000. Sigma Planning Corp acquired a new position in shares of Tempus AI during the 3rd quarter worth about $1,323,000. Davidson Kempner Capital Management LP bought a new stake in shares of Tempus AI in the 2nd quarter valued at about $2,271,000. NEA Management Company LLC acquired a new stake in shares of Tempus AI in the 2nd quarter valued at approximately $160,048,000. Finally, Exchange Traded Concepts LLC bought a new position in Tempus AI during the 3rd quarter worth approximately $3,458,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.